Cutaneous disorders and viral gene expression in HIV-1 transgenic mice.
Patients infected with HIV-1 experience several hyperproliferative skin disorders, including seborrheic dermatitis, ichthyosis, and psoriasis. Transgenic mice carrying a subgenomic HIV-1 proviral construct lacking the gag and pol genes were found to develop proliferative epidermal lesions, manifested as diffuse epidermal hyperplasia in homozygous transgenic mice and benign papillomas in heterozygous transgenic mice. Nonpapillomatous skin from both homozygotes and heterozygotes expressed viral RNA, and the viral envelope protein gp120 was localized to the suprabasal keratinocyte. Papillomas contained increased amounts of both viral mRNA and envelope glycoprotein. Exposure of transgenic mice to doses of ultraviolet B (UV-B) irradiation that induced cutaneous injury increased viral gene expression and resulted in the development of papillomas within 14-21 days. Cutaneous injury induced by phenol and liquid nitrogen had similar effects. These data support a role for HIV-1 gene products in the pathogenesis of proliferative epidermal disorders associated with HIV-1 infection. Further, they suggest that the process of wound repair increases HIV-1 gene expression in this transgenic mouse model.
Kopp
J B
JB
Laboratory of Developmental Biology, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.
Rooney
J F
JF
Wohlenberg
C
C
Dorfman
N
N
Marinos
N J
NJ
Bryant
J L
JL
Katz
S I
SI
Notkins
A L
AL
Klotman
P E
PE
D000818:Animals; D015152:Blotting, Northern; D015870:Gene Expression; D005814:Genes, Viral; D015658:HIV Infections / Q000150:complications* / Q000235:genetics; D015497:HIV-1 / Q000235:genetics*; D007124:Immunoenzyme Techniques; D051379:Mice; D008822:Mice, Transgenic; D012871:Skin Diseases / Q000150:complications* / Q000473:pathology